TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35305845

Group type: EXPERIMENTAL
Intervention: Interactive immersive VR environment during burn wound care (Mean = 71.06, SD = 26.86)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nature pictures viewed in VR goggles (Mean = 68.19, SD = 29.26)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Computer generated VR during wound care (Mean = 54.23, SD = 26.13)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No distraction (No VR) during wound care (Mean = 63.85, SD = 31.50)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Interactive immersive VR
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nature pictures
Number of subjects: 48
Study: 33467951

Group type: EXPERIMENTAL
Intervention: Propolis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cryotherapy (sucking ice cubes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OraLife, sea buckthorn pulp oil, marshmallow root tea, Helago chamomile oil, mare milk, Saliva Natura
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mouthwashes (teas, supplements, oil applications)
Number of subjects: 0
Study: 35175284

Group type: COMPARATOR
Intervention: Black race compared with White race
Number of subjects: 9719

Group type: COMPARATOR
Intervention: Medicare
Number of subjects: 9719

Group type: COMPARATOR
Intervention: Medicaid
Number of subjects: 9719

Group type: COMPARATOR
Intervention: Neighborhoods in the highest NDI quartile
Number of subjects: 9719
Study: 33147353

Group type: EXPERIMENTAL
Intervention: CSLA
Number of subjects: 90

Group type: COMPARATOR
Intervention: DNTP
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 33106892

Group type: EXPERIMENTAL
Intervention: Sucroferric oxyhydroxide (SFOH)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Calcium acetate (CaAc)
Number of subjects: 85
Study: 33240572

Group type: EXPERIMENTAL
Intervention: Negative pressure application at 25% of baseline IOP for 20 minutes
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Negative pressure application at 50% of baseline IOP for 20 minutes
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Negative pressure application at 75% of baseline IOP for 20 minutes
Number of subjects: 65

Group type: COMPARATOR
Intervention: No negative pressure application (control)
Number of subjects: 65
Study: 35689673

Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis (DBT)
Number of subjects: 73866

Group type: COMPARATOR
Intervention: Digital Mammography (DM)
Number of subjects: 73866
Study: 33253391

Group type: EXPERIMENTAL
Intervention: MSC-IT (1 × 10^6/kg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: MSC-IV (1 × 10^6/kg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 48
Study: 36164687

Group type: EXPERIMENTAL
Intervention: AUT00206
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33637332

Group type: EXPERIMENTAL
Intervention: Tegoprazan (100 mg/d) with triple-antibiotic therapy (1500 mg/d metronidazole, 2000 mg/d tetracycline, and 1200 mg/d bismuth) for 7 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Triple-antibiotic therapy (1500 mg/d metronidazole, 2000 mg/d tetracycline, and 1200 mg/d bismuth) with tegoprazan for 7 days
Number of subjects: 21
Study: 32528467

Group type: EXPERIMENTAL
Intervention: Tick-borne encephalitis (TBE) vaccine
Number of subjects: 73
Study: 36240389

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: CMAC videolaryngoscope
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Smart Trach videolaryngoscope
Number of subjects: 375

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 375
Study: 32590453

Group type: EXPERIMENTAL
Intervention: ImmunoRatio
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Counting by CP1
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Counting by CP2
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Visual estimation (EB)
Number of subjects: 204
Study: 32639369

Group type: EXPERIMENTAL
Intervention: Placebo group (informed it may be a local anaesthetic cream)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group (informed the cream was inactive)
Number of subjects: 237
Study: 33004536

Group type: EXPERIMENTAL
Intervention: Abituzumab 1500 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Abituzumab 500 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32340820

Group type: EXPERIMENTAL
Intervention: Ketamine (4 mg/kg IM or 1 mg/kg IV)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Haloperidol (5-10 mg IM or IV) + Lorazepam (1-2 mg IM or IV)
Number of subjects: 93
Study: 32034312

Group type: EXPERIMENTAL
Intervention: Suprapubic pedicled phalloplasty (SPP)
Number of subjects: 34
Study: 35742327

Group type: EXPERIMENTAL
Intervention: Active air filtration intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham air filtration intervention
Number of subjects: 38
Study: 33689608

Group type: EXPERIMENTAL
Intervention: Intraocular lens dislocation cases
Number of subjects: 508

Group type: COMPARATOR
Intervention: Controls (without intraocular lens dislocation)
Number of subjects: 508
Study: 32573670

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mg/kg)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control (0.9% sodium chloride)
Number of subjects: 394
Study: 34801998

Group type: EXPERIMENTAL
Intervention: 30-min aerobic exercise on a cycle ergometer
Number of subjects: 8

Group type: COMPARATOR
Intervention: Resting moment (30-min sitting in a chair)
Number of subjects: 8
Study: 34009015

Group type: EXPERIMENTAL
Intervention: Glyphosate (GLY)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Aminomethylphosphonic Acid (AMPA)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 247
Study: 36347106

Group type: EXPERIMENTAL
Intervention: Guided group (standard PE + virtual, clinician-guided IVEs with Bio Ware)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-Guided group (standard PE + self-guided IVEs with Bio Ware)
Number of subjects: 40
Study: 33715077

Group type: EXPERIMENTAL
Intervention: TEGAFOX (tegafur–uracil/leucovorin plus oxaliplatin)
Number of subjects: 159

Group type: COMPARATOR
Intervention: UFT/LV (tegafur–uracil/leucovorin)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: TEGAFOX
Number of subjects: 159

Group type: COMPARATOR
Intervention: UFT/LV
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: TEGAFOX and UFT/LV
Number of subjects: 159
Study: 32840597

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (4000 IU/d)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 35239175

Group type: EXPERIMENTAL
Intervention: High-volume hemodiafiltration
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: High-volume hemodiafiltration (subgroup with convective volume > 27.5 L)
Number of subjects: 193
Study: 32858227

Group type: EXPERIMENTAL
Intervention: Geriatric Emergency Department Innovations (GEDI) program
Number of subjects: 840

Group type: COMPARATOR
Intervention: Usual ED care
Number of subjects: 840
Study: 35623576

Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 81

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Repeat challenges
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Symptom pattern reproducibility
Number of subjects: 81
Study: 35749350

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Combined model
Number of subjects: 204

Group type: COMPARATOR
Intervention: Baseline model
Number of subjects: 204

Group type: COMPARATOR
Intervention: Radiologists' performance
Number of subjects: 204
Study: 34870120

Group type: EXPERIMENTAL
Intervention: Preoperative pain neurophysiology education in addition to routine education (n=21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Routine education only (control group, n=20)
Number of subjects: 41
Study: 33612485

Group type: EXPERIMENTAL
Intervention: Epinephrine plus vasopressin (0.1 mL per kg vasopressin, 0.1 mL per kg epinephrine 1:10000)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Epinephrine plus placebo (0.1 mL per kg normal saline, 0.1 mL per kg epinephrine 1:10000)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epinephrine plus vasopressin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Epinephrine plus placebo
Number of subjects: 90
Study: 32324755

Group type: EXPERIMENTAL
Intervention: Support from others than family/friends
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Support from family
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Support from friends
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Academic performance
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Activeness of participation in school activities
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Harmonious relationship with teachers/classmates
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Health over the last year
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Regular physical exercise
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Being female
Number of subjects: 4681

Group type: EXPERIMENTAL
Intervention: Extreme worry about their own lives
Number of subjects: 4681
Study: 35837022

Group type: EXPERIMENTAL
Intervention: Phenylephrine 40, 50, 60, 70, and 80 μg for severe preeclampsia
Number of subjects: 150

Group type: COMPARATOR
Intervention: Phenylephrine 70, 80, 90, 100, and 110 μg for normotension
Number of subjects: 150
Study: 34214822

Group type: EXPERIMENTAL
Intervention: My Memory Forest intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 56
Study: 34964395

Group type: EXPERIMENTAL
Intervention: Aerobic dance program (45 minute sessions two days per week over eight weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No-PE control group
Number of subjects: 41
Study: 33935121

Group type: EXPERIMENTAL
Intervention: Evidence-based nursing intervention
Number of subjects: 116
Study: 35346389

Group type: EXPERIMENTAL
Intervention: Kinesiology tape, elevation and massage (Trial Treatment - TT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Treatment as usual (compression, elevation and massage - TAU)
Number of subjects: 26
Study: 34551130

Group type: EXPERIMENTAL
Intervention: eptinezumab 100 mg
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: eptinezumab 300 mg
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: eptinezumab (both doses)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: eptinezumab
Number of subjects: 431
Study: 35093129

Group type: EXPERIMENTAL
Intervention: Intertruncal approach to the supraclavicular block (IA-SB)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Classical approach to the supraclavicular block (CA-SB)
Number of subjects: 122
Study: 33045536

Group type: EXPERIMENTAL
Intervention: Laser tongue debridement (LTD) with an Er,Cr:YSGG solid state laser
Number of subjects: 54
Study: 33303222

Group type: EXPERIMENTAL
Intervention: EPA (3 g/day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: DHA (3 g/day)
Number of subjects: 21
Study: 35245642

Group type: EXPERIMENTAL
Intervention: Fit U intervention
Number of subjects: 267

Group type: COMPARATOR
Intervention: Self-monitoring only group
Number of subjects: 267
Study: 33094919

Group type: EXPERIMENTAL
Intervention: Before breakfast (BB)
Number of subjects: 140
Study: 34187833

Group type: EXPERIMENTAL
Intervention: Home-based self-collection of anal canal specimen at 0 and 12 months
Number of subjects: 400

Group type: COMPARATOR
Intervention: Clinic-based clinician collection of anal canal specimen at 0 and 12 months
Number of subjects: 400
Study: 33035700

Group type: EXPERIMENTAL
Intervention: IND/GLY/MF 150/50/160 μg
Number of subjects: 36
Study: 34302941

Group type: EXPERIMENTAL
Intervention: High repetition-load resistance training (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low repetition-load resistance training (n = 28)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Resistance training intervention
Number of subjects: 60
Study: 32328662

Group type: EXPERIMENTAL
Intervention: Continuing adjuvant temozolomide (up to 12 cycles)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Stopping adjuvant temozolomide (control arm)
Number of subjects: 159
Study: 35016561

Group type: EXPERIMENTAL
Intervention: Total Body Recumbent Stepping (TBRS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Treadmill Walking (TM)
Number of subjects: 19
Study: 33787831

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg once daily)
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 32086921

Group type: EXPERIMENTAL
Intervention: Dysosmia group (n=64)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-dysosmia group (n=41)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Female patients with olfactory dysfunction
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Male patients with olfactory dysfunction
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: SCL-90 score of chronic sinusitis patients with olfactory dysfunction (n=64)
Number of subjects: 105

Group type: COMPARATOR
Intervention: SCL-90 score of chronic sinusitis patients without olfactory dysfunction (n=41)
Number of subjects: 105
Study: 32208999

Group type: EXPERIMENTAL
Intervention: Video decision aid plus standard verbal counseling
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard verbal counseling alone
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Video decision aid
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Verbal counseling duration
Number of subjects: 31
Study: 33606892

Group type: EXPERIMENTAL
Intervention: Favipiravir (FAV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Internal standard (Lamivudine)
Number of subjects: 0
Study: 35575587

Group type: EXPERIMENTAL
Intervention: Ribociclib plus letrozole (Ribociclib 600 mg once daily for 3 weeks on/1 week off, Letrozole 2.5 mg continuously)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Ribociclib plus letrozole
Number of subjects: 339
Study: 33507500

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control
Number of subjects: 246
Study: 35224090

Group type: EXPERIMENTAL
Intervention: Continuous Passive Movement (CPM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physical therapy alone (non-CPM group)
Number of subjects: 60
Study: 33038506

Group type: EXPERIMENTAL
Intervention: Cardiovascular Health (CVH) mHealth intervention, addressing behaviors related to CVD risk.
Number of subjects: 302

Group type: COMPARATOR
Intervention: Whole Health (WH) mHealth intervention, addressing behaviors unrelated to CVD.
Number of subjects: 302
Study: 36151855

Group type: EXPERIMENTAL
Intervention: Vortioxetine with central monitoring of QIDS‐J and MADRS ratings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33777184

Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SFI)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 13
Study: 32199755

Group type: EXPERIMENTAL
Intervention: Noninvasive marker-based follow-up (UroVysion, NMP22, urine cytology, and ultrasound)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Usual care with cystoscopy
Number of subjects: 185
Study: 35618629

Group type: EXPERIMENTAL
Intervention: Platinum-doublet chemotherapy plus radiotherapy with pembrolizumab (Group A)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Platinum-doublet chemotherapy plus radiotherapy with pembrolizumab plus olaparib (Group B)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Durvalumab monotherapy (Group C)
Number of subjects: 190
Study: 33413304

Group type: EXPERIMENTAL
Intervention: Gamified app
Number of subjects: 58

Group type: COMPARATOR
Intervention: Simple app
Number of subjects: 58
Study: 35264432

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg + MTX
Number of subjects: 584

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg or Baricitinib 4 mg + MTX
Number of subjects: 584
Study: 33638221

Group type: EXPERIMENTAL
Intervention: Oral vancomycin (OVT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 0
Study: 33424089

Group type: EXPERIMENTAL
Intervention: Group A: 1gr/8hours IV acetaminophen and 50mg/6hours IM pethidine
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Group B: 1gr/8hours IV acetaminophen and 40mg/12hours IV parecoxib
Number of subjects: 259

Group type: COMPARATOR
Intervention: Group C: 1gr/8hours IV acetaminophen monotherapy
Number of subjects: 259
Study: 36128685

Group type: EXPERIMENTAL
Intervention: Enhanced follow-up by stoma therapists (STs) with regular consultations after discharge.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard follow-up without enhanced management.
Number of subjects: 0
Study: 33940389

Group type: EXPERIMENTAL
Intervention: Soticlestat (up to 300 mg BID)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All participants (Soticlestat in Part B)
Number of subjects: 18
Study: 35119781

Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 25 mmHg (LBNP25)
Number of subjects: 9
Study: 32895116

Group type: EXPERIMENTAL
Intervention: CPAP with a telemonitoring system
Number of subjects: 60

Group type: COMPARATOR
Intervention: CPAP with usual care
Number of subjects: 60
Study: 34634436

Group type: EXPERIMENTAL
Intervention: Dose-escalated chemoradiation (5 × 3 gray boost + CRT)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard chemoradiation (control group)
Number of subjects: 115
Study: 33091173

Group type: EXPERIMENTAL
Intervention: SGLT2i (Dapagliflozin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34050531

Group type: EXPERIMENTAL
Intervention: Immediate delivery of an oral health intervention
Number of subjects: 448

Group type: COMPARATOR
Intervention: Delayed delivery of an oral health intervention
Number of subjects: 448
Study: 32468652

Group type: EXPERIMENTAL
Intervention: Neoadjuvant systemic therapy
Number of subjects: 0
Study: 36442199

Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 34406395

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 35390512

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CTD)
Number of subjects: 13523

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 13523
Study: 33743631

Group type: EXPERIMENTAL
Intervention: Keratoconus stage 1
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Keratoconus stage 2
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Keratoconus stage 3
Number of subjects: 150
Study: 32991233

Group type: EXPERIMENTAL
Intervention: Experimental therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35279655

Group type: EXPERIMENTAL
Intervention: HD + MCO
Number of subjects: 14

Group type: COMPARATOR
Intervention: mixed-dilution olHDF
Number of subjects: 14
Study: 32387569

Group type: EXPERIMENTAL
Intervention: Anophthalmic side
Number of subjects: 87
Study: 34719355

Group type: EXPERIMENTAL
Intervention: Single‐puncture Type‐1 arthrocentesis (SPA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional double‐puncture arthrocentesis (DPA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (SPA and DPA)
Number of subjects: 50
Study: 36318635

Group type: EXPERIMENTAL
Intervention: Post-acute care (PAC) utilization
Number of subjects: 718737

Group type: EXPERIMENTAL
Intervention: PAC cost
Number of subjects: 718737

Group type: EXPERIMENTAL
Intervention: Hospital readmissions
Number of subjects: 718737

Group type: EXPERIMENTAL
Intervention: Days alive in the community
Number of subjects: 718737

Group type: EXPERIMENTAL
Intervention: 180-day Medicare costs
Number of subjects: 718737

Group type: EXPERIMENTAL
Intervention: Mortality
Number of subjects: 718737
Study: 33230029

Group type: EXPERIMENTAL
Intervention: Nurse-initiated and monitored ART (NIMART)
Number of subjects: 1760

Group type: COMPARATOR
Intervention: Clinician-initiated and monitored ART
Number of subjects: 1760
Study: 32773608

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 785

Group type: COMPARATOR
Intervention: Phacoemulsification cataract surgery (PCS)
Number of subjects: 785
Study: 33558417

Group type: EXPERIMENTAL
Intervention: Digital personality change intervention using the smartphone application PEACH for 3 months
Number of subjects: 1523

Group type: COMPARATOR
Intervention: Waitlist control group (1 month delay before receiving the intervention)
Number of subjects: 1523

Group type: EXPERIMENTAL
Intervention: Digital personality change intervention
Number of subjects: 1523
Study: 35120326

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 682

Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 682
Study: 33960263

Group type: EXPERIMENTAL
Intervention: S-STOP program (intervention)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control group (delayed implementation)
Number of subjects: 303
Study: 32795986

Group type: EXPERIMENTAL
Intervention: Facebook recruitment method
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: TV advertisements recruitment method
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: Public bus interior card advertising recruitment method
Number of subjects: 1417
Study: 35248042

Group type: EXPERIMENTAL
Intervention: Mild CS (2 mm < DH decrease ≤ 4 mm)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Severe CS (DH decrease > 4 mm)
Number of subjects: 242

Group type: COMPARATOR
Intervention: No CS (DH decrease ≤ 2 mm)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: CS related risk factors
Number of subjects: 242